| Date Filed | Type | Description |
| 05/17/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/22/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/18/2018 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 12/12/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/14/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/31/2016 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| 02/16/2016 |
SC 13G/A
| DERMA MEDICAL SYSTEMS INC. has filed a Schedule 13D for TARGETED MEDICAL PHARMA, INC. |
| 11/13/2015 |
10-Q
| Quarterly Report for the period ended September 30, 2015 |
| 10/01/2015 |
8-K
| Quarterly results |
| 08/13/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
| 05/15/2015 |
10-Q
| Quarterly Report for the period ended March 31, 2015 |
| 04/14/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/03/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/27/2015 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 02/11/2015 |
SC 13G/A
| DERMA MEDICAL SYSTEMS INC. reports a 17.2% stake in TARGETED MEDICAL PHARMA, INC. |
| 02/06/2015 |
8-K
| Resignation/termination of a director |
| 01/20/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 01/12/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/07/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/06/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/14/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 08/14/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 06/11/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/20/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 05/20/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 04/30/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/09/2014 |
SC 13G
| DERMA MEDICAL SYSTEMS INC. reports a 9.2% stake in TARGETED MEDICAL PHARMA, INC. |
| 04/01/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/31/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/11/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma’ s Board of Directors Los Angeles, March 5, 2014 –Targeted Medical Pharma, Inc. today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company’ s board of directors. A nationally respected expert in healthcare, medical and hospital administration in Australia, Dr. Wenkart established Macquarie Health Corporation in Sydney, Australia in 1976. His organization owns and operates eleven private hospitals in Australia, and is one of the nation’ s leading providers of healthcare services. Dr. Wenkart is a graduate of the Sydney University School of Medicine. In 1976, he established the Health Care Research Institute and the Wenkart Foundation which supports the Art...",
"Dr. Tom Wenkart - Bio" |
|
| 01/02/2014 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 11/13/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
| 10/07/2013 |
8-K
| Form 8-K - Current report |
| 09/09/2013 |
8-K
| Form 8-K - Current report |
|